Related Experiment Video

Updated: Jun 8, 2026

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response
12:50

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response

Published on: September 15, 2017

[Effect of tectorigenin on MCP-1 and ICAM-1 mRNA expression in injured vascular endothelial cells]

Jinfeng Wang1, Yanping Zhang, Cuiyan Yang

  • 1Cardiac Intervention Department of 208th Hospital of PLA, Changchun 130062, China. 13944927368@139.com

Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica
|October 12, 2010
PubMed
Abstract

Insights

Tectorigenin protects vascular endothelial cells from oxidant injury and inhibits key inflammatory markers, offering a potential therapeutic mechanism against atherosclerosis.

Area of Science:

  • Cardiovascular Research
  • Molecular Biology
  • Pharmacology

Background:

  • Atherosclerosis is a chronic inflammatory disease.
  • Oxidized low-density lipoprotein (ox-LDL) is a key factor in vascular endothelial cell injury.
  • Understanding protective mechanisms is crucial for developing anti-atherosclerosis therapies.

Purpose of the Study:

  • To investigate the protective effects of tectorigenin on vascular endothelial cells (VECs) damaged by ox-LDL.
  • To examine the impact of tectorigenin on the expression of MCP-1 and ICAM-1 mRNA.
  • To elucidate the anti-atherosclerosis mechanism of tectorigenin.

Main Methods:

  • In vitro culture of rat VECs.
  • Induction of oxidant injury using 100 mg/L ox-LDL.
  • Assessment of VEC viability using MTT colorimetry.
  • Quantification of MCP-1 and ICAM-1 mRNA expression via RT-PCR.

Main Results:

  • Tectorigenin demonstrated a significant protective effect on ox-LDL-injured VECs.
  • Tectorigenin markedly inhibited the overexpression of MCP-1 and ICAM-1 mRNA.
  • The compound's dosage-dependent effects were observed.

Conclusions:

  • Tectorigenin prevents VEC oxidant injury, a critical mechanism in anti-atherosclerosis.
  • Inhibition of MCP-1 and ICAM-1 expression by tectorigenin contributes to its anti-atherosclerotic properties.
  • Tectorigenin shows promise as a therapeutic agent for preventing atherosclerosis.

More Related Videos

Isolation of Endothelial Progenitor Cells from Healthy Volunteers and Their Migratory Potential Influenced by Serum Samples After Cardiac Surgery08:43

Isolation of Endothelial Progenitor Cells from Healthy Volunteers and Their Migratory Potential Influenced by Serum Samples After Cardiac Surgery

Published on: February 14, 2017

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling07:49

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling

Published on: August 3, 2018

Related Concept Videos

Tissue Injury: Inflammation and Repair01:28

Tissue Injury: Inflammation and Repair

Following injury, the integrity of the injured tissues must be reestablished. For example, in skin tissue, wound repair involves coordination among resident skin cells, blood mononuclear cells, extracellular matrix, growth factors, and cytokines to complete the healing cascade.
Formation of Blood Clot
In case of deep injuries, trauma to blood vessels results in blood loss. In the meantime, phospholipids released from the ruptured endothelial cellular membrane are converted into arachidonic...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...